AI assistant
Sending…
Inogen Inc — Director's Dealing 2021
Oct 1, 2021
33625_dirs_2021-09-30_8d065377-332a-4566-b7d7-354aa642c09a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-09-28
Reporting Person: Taylor Brenton (EVP, Engineering)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-28 | Common Stock | M | 12945 | $0.81 | Acquired | 69735 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-28 | Stock Option (Right to Buy) | $0.81 | M | 12945 | Disposed | 2022-03-27 | Common Stock (12945) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 842 | Indirect |
Footnotes
F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting
commencement date. The vesting commencement date for this option is May 1, 2012.
More from Inogen Inc
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27